References
- 1. Akil, I., Yilmaz, O., Kuruepe, S., Deqwrli, K., Kavukcu, S. (2006). Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora. Pediatr Nephrol. 21, 807-810. https://doi.org/10.1007/s00467-006-0088-4 PMid:1670337410.1007/s00467-006-0088-4PMid:16703374
- 2. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I. (2005). Host bacterial mutualism in the human intestine. Science 307, 1915-1920. https://doi.org/10.1126/science.1104816 PMid:1579084410.1126/.1104816PMid:15790844
- 3. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (7285): 59-65. https://doi.org/10.1038/nature08821 PMid:20203603 PMCid:PMC377980310.1038/nature08821PMid:20203603PMCid:PMC3779803
- 4. Penders, J., Thijs, C., Vink, C., Stelma, F.F., Snijders, B., Kummeling, I., van den Brandt, P.A., Stobberingh, E.E. (2006). Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118 (2): 511-521. https://doi.org/10.1542/peds.2005-2824 PMid:1688280210.1542/peds.2005-2824PMid:16882802
- 5. Jernberg, C., Lofmark, S., Edlund, C., Jansson, J.K. (2010). Long – term ecological impacts of antibiotic administration on the human intestinal microbiota. Microbiology 156, 3216-3223. https://doi.org/10.1099/mic.0.040618-0 PMid:2070566110.1099/mic.0.040618-0PMid:20705661
- 6. de la Cochetiere, M.F., Durand, T., Lepage, P., Bourreille, A., Galmiche, J.P., Dore, J. (2005). Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43, 5588-5592. https://doi.org/10.1128/JCM.43.11.5588-5592.2005 PMid:16272491 PMCid:PMC128778710.1128/JCM.43.11.5588-5592.2005PMid:16272491PMCid:PMC1287787
- 7. Perez-Cobas, A.E., Gosalbes, M.J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., et al. (2013). Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62, 1591-1601. https://doi.org/10.1136/gutjnl-2012-303184 PMid:23236009 PMCid:PMC381289910.1136/gutjnl-2012-303184PMid:23236009PMCid:PMC3812899
- 8. Paterson, L.D., Bonomo, A.R. (2005). Extended spectrum beta lactamases: a clinical update. Clin Microbiol Rev. 18(4): 657-686. https://doi.org/10.1128/CMR.18.4.657-686.2005 PMid:16223952 PMCid:PMC126590810.1128/CMR.18.4.657-686.2005
- 9. Bush, K., Jacoby, G.A. (2010). Update functional classification sheme of β – lactamases. Antimicrob Agents Chemother. 54(3): 969-976. https://doi.org/10.1128/AAC.01009-09 PMid:19995920 PMCid:PMC282599310.1128/AAC.01009-09PMid:19995920PMCid:PMC2825993
- 10. Philippon, A., Labia, R., Jacoby, G. (1989). Extended-spectrum β-lactamases.Antimicrob Agents Chemother. 33, 1131–1136. https://doi.org/10.1128/AAC.33.8.113110.1128/AAC.33.8.1131
- 11. Srivastava, A., Singhal, N., Goel, M., Virdi, J.S., Kumar, M. (2014). CBMAR: a comprehensive β-lactamase molecular annotation resource. Database (Oxford). 2014: bau111 https://doi.org/10.1093/database/bau111 PMid:25475113 PMCid:PMC425506010.1093/database/bau111PMid:25475113PMCid:PMC4255060
- 12. Bonnet, R. (2004). Growing group of extended spectrum: the CTX-M enzymes. Antimicrob Agent Chemother. 48, 1-14 https://doi.org/10.1128/AAC.48.1.1-14.2004 PMCid:PMC31018710.1128/AAC.48.1.1-14.2004PMCid:PMC310187
- 13. Lewis, J.S., Herrera, M., Wickes, B., Patterson, J.E., Jorgensen, J.H. (2007). First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System. Antimicrob Agents Chemother. 51(11): 4015-4021. https://doi.org/10.1128/AAC.00576-07 PMid:17724160 PMCid:PMC215143810.1128/AAC.00576-07PMid:17724160PMCid:PMC2151438
- 14. Alobwede, I., Mzali, F.H., Livermore, D.M., Hentige, J., Todd, N., Hawkey, P.M. (2003). CTX-M extended-spectrum beta-lactamases arrives in UK. J Antimicrob Chemother. 51. 470-471. https://doi.org/10.1093/jac/dkg096 PMid:12562729 139 Popova G. et al.10.1093/jac/dkg096PMid:12562729139PopovaG.etal
- 15. Mendonça, N., Ferreira, E., Louro, D., ARSIP Participants, Caniça, M. (2009). Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int J Antimicrob Agents. 34(1): 29-37. https://doi.org/10.1016/j.ijantimicag.2008.11.014 PMid:1927275710.1016/j.ijantimicag.2008.11.014PMid:19272757
- 16. Kiratisin, P., Apisarnthanarak, A., Laesripa, C., Saifon, P. (2008). Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 52(8): 2818-2824. https://doi.org/10.1128/AAC.00171-08 PMid:18505851 PMCid:PMC249313610.1128/AAC.00171-08
- 17. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014. http://www.eucast.org.
- 18. The EUCAST subcommittee for detection of resistance mechanisms and specific resistance of clinical and/or epidemiological importance. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance.Version 1.0, 2013. http://www.eucast.org.
- 19. Ribot, E.M., Fair, M.A., Gautom, R., Cameron, D.N., Hunter, S.B., Swaminathan, B., Barrett, T.J. (2006). Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 3(1): 59-67. https://doi.org/10.1089/fpd.2006.3.59 PMid:1660298010.1089/fpd.2006.3.59PMid:16602980
- 20. Caprioli, A., Maugliani, A., Michelacci, V., Morabito, S. (2014). Molecular typing of Verocytotoxin -producing E. coli (VTEC) strains isolated from food, feed and animals : state of play and standard operating procedures for pulsed field gel electrophoresis (PFGE) typing, profiles interpretation and curation. EFSA journal EN704, 55.10.2903/sp.efsa.2014.EN-704
- 21. Barrett, T.J., Gerner-Smidt, P., Swaminathan, B. (2006). Interpretation of pulsed-field gel electrophoresis patterns in foodborne disease investigations and surveillance. Foodborne Pathog Dis. 3(1): 20-31. https://doi.org/10.1089/fpd.2006.3.20 PMid:1660297610.1089/fpd.2006.3.20PMid:16602976
- 22. Peters, T.M., Maguire, C., Threlfall, E.J., Fisher, I.S., Gill, N., Gatto, A.J. (2003). The Salm-gene project -a European collaboration for DNA fingerprinting for food-related salmonellosis. Euro Surveill. 8, 46-50. https://doi.org/10.2807/esm.08.02.00401-en PMid:1263197510.2807/esm.08.02.00401-enPMid:12631975
- 23. Winokur, P.L., Cantón, R., Casellas, J.M., Legakis, N. (2001). Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis. 32, 94–103. https://doi.org/10.1086/320182 PMid:1132045010.1086/320182PMid:11320450
- 24. Pitout, J.D., Hanson, N.D., Church, D.L., Laupland, K.B. (2004). Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum β-lactamases: importance of community isolates withblaCTX-M genes. Clin Infect Dis. 38, 1736–1741. https://doi.org/10.1086/421094 PMid:1522762010.1086/421094PMid:15227620
- 25. Ben-Ami, R., Schwaber, M.J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., Carmeli, Y. (2006). Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis. 42, 925–934. https://doi.org/10.1086/500936 PMid:1651175410.1086/500936PMid:16511754
- 26. Chandramohan, L., Revell, P.A. (2012). Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing enterobacteriaceae in a pediatric patient population. Antimicrob Agents Chemother. 56(9): 4765-4770. https://doi.org/10.1128/AAC.00666-12 PMid:22733062 PMCid:PMC342190110.1128/AAC.00666-12PMid:22733062PMCid:PMC3421901
- 27. Mitchella, D.J., Mc Clurea, B.G., Tubmanb, T.R.J. (2001). Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring in milk fed infants. Arch Dis Child. 84, 273-276. https://doi.org/10.1136/adc.84.3.273 PMCid:PMC171869710.1136/adc.84.3.273PMCid:PMC1718697
- 28. Orozco-Levi, M., Torres, A., Ferrer, M., Piera, C., El-Ebiary, M., de la Bellacasa, J.P., Rodriguez-Roisin, R. (1995). Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal re- flux in mechanically ventilated patients. Am J Respir Crit Care Med. 152, 1387–1390. https://doi.org/10.1164/ajrccm.152.4.7551400 PMid:7551400 140 PFGE for typing extended-spectrum-β-lactamases- producing Escherichia coli from respiratory and digestive system10.1164/ajrccm.152.4.7551400
- 29. Davis, K.J., Johannigman, J.A., Campbell, R.S., Marraccini, A., Luchette, F.A., Frame, S.B., Branson, R.D. (2001). The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury. Crit Care. 5, 81–87. https://doi.org/10.1186/cc991 PMid:11299066 PMCid:PMC3071310.1186/cc991PMid:11299066PMCid:PMC30713
- 30. Drakulovic, M.B., Torres, A., Bauer, T.T., Nicolas, J.M., Nogue, S., Ferrer, M. (1999). Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354, 1851–1858. https://doi.org/10.1016/S0140-6736(98)12251-110.1016/S0140-6736(98)12251-1
- 31. Pingleton, S.K., Hinthorn, D.R., Liu, C. (1986). Enteral nutrition in patients receiving mechanical ventilation: multiple sources of tracheal colonization include the stomach. Am J Med. 80, 827–832. https://doi.org/10.1016/0002-9343(86)90623-610.1016/0002-9343(86)90623-6
- 32. Tablan, O.C., Anderson, L.J., Besser, R., Bridges, C., Hajjeh, R., Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. (2004). Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 53(RR-3):1–36. PMid:15048056
- 33. Prosperi, M., Veras, N., Azarian, T., Rathore, M., Nolan, D., Rand, K., Cook, R.L., Johnson, J., Morris, J.G., Salemil, M. (2013). Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in the genomic era: a cross-sectional study. Sci Rep. 3, 1902 https://doi.org/10.1038/srep01902 PMid:23712667 PMCid:PMC366495610.1038/srep01902PMid:23712667PMCid:PMC3664956
- 34. Tschudin-Sutter, S., Frei, R., Dangel, M., Strauden A., Widmer, A.T. (2012). Rate of Transmission of extended-spectrum beta-lactamase–producing enterobacteriaceae without contact isolation. Clin Infect Dis. 55 (11): 1505-1511. https://doi.org/10.1093/cid/cis770 PMid:2295543610.1093/cid/cis770PMid:22955436
- 35. Jain, R., Kralovic, S.M., Evans, M.E., Ambrose, M., Simbartl, L.A., Obrosky, D.S., Render, M.L., Freyberg, R.W., Jarnigan, J.A., Muder, R.R., Miller, L.J., Roselle, G.A. (2011). Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 364:1419-30. https://doi.org/10.1056/NEJMoa1007474 PMid:2148876410.1056/NEJMoa1007474PMid:21488764
- 36. Ostrowsky, B.E., Trick, W.E., Sohn, A.H., Quirk, S.B., Holt, S., Carson, L.A., Hill, B.C., Arduino, M.J., Kuehnert, M.J., Jarvis, W.R. (2001). Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 344: 1427-1433. https://doi.org/10.1056/NEJM200105103441903 PMid:1134680710.1056/NEJM200105103441903PMid:11346807